Rgenta Therapeutics

0 followers

Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders.

Industries

Employees

11-50

Links


Org chart

Simon Xi
Co-Founder & CEO
Collapse
Travis Wager
Co-Founder, President and CSO
Kathryn Gregory
VP, Business Development
Missy Fulton
Director ,People Strategy

Board & advisors

Zhiping Weng
Co-Founder & Head of SAB
Charles DeLisi
Scientific Advisor
Philip Zamore
Scientific Advisor
Nicholas Johnson
Scientific Advisor
Darren Monckton
Scientific Advisor
Richard Myers
Consultant
Hongbo Lu
Director
Roger Sun
Director
Xiaogang Pan
Director
Julia Kaufman
Member Board of Directors
Dezhi Kang
Director
Sarah Tabrizi
Scientific Advisor
Alan Ho
Advisor